Emergent BioSolutions Inc. said on Monday it received marketing authorization for its oral typhoid vaccine Vivotif in five European Union nations including France, Portugal, Poland, Czech Republic and Slovakia.

Typhoid fever is a potentially severe and life-threatening infection caused by the bacterium Salmonella enterica serovar Typhi (Salmonella Typhi) and is contracted by ingesting contaminated food or water. It is unique to humans and commonly found where sanitation is deficient. Millions of people are affected by typhoid fever annually, and if left untreated, serious complications such as hemorrhaging may occur.

Read more…